A Phase I/II Randomized Trial of Higher Dose mRNA-1273 Boosters in Lung Transplant Recipients
Abstract
(ISSN 2577-5820)
OBM Transplantation (ISSN 2577-5820) is an international peer-reviewed Open Access journal published quarterly online by LIDSEN Publishing Inc., which covers all evidence-based scientific studies related to transplantation, including: transplantation procedures and the maintenance of transplanted tissues or organs; assimilation of grafted tissue and the reconstitution of removed organs or parts of organs; transplantation of heart, lung, kidney, liver, pancreatic islets and bone marrow, etc. Areas related to clinical and experimental transplantation are also of interest.
OBM Transplantation is committed to rapid review and publication, and we aim at serving the international transplant community with high accessibility as well as relevant and high quality content.
The journal publishes all types of articles in English. There is no restriction on the length of the papers. We encourage authors to be concise but present their results in as much detail as necessary, as reviewers are expected to emphasize scientific rigor and reproducibility.
Publication Speed (median values for papers published in 2023): Submission to First Decision: 6.7 weeks; Submission to Acceptance: 14.4 weeks; Acceptance to Publication: 6 days (1-2 days of FREE language polishing included)
Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Fanconi Anemia: Results of a Single Center with a Fludarabine-Based Conditioning Regimenby
Sabrine Mekni
,
Lamia Torjemane
,
Malek Khayati
,
Dorra Belloumi
,
Rimmel Yosra Kanoun
,
Insaf Ben Yaiche
,
Rihab Ouerghi
,
Ines Turki
,
Saloua Ladeb
,
Tarek Ben Othman
and
Nour Ben Abdeljelil
Abstract Allogeneic hematopoietic stem cell transplantation (Allo-HSCT) remains the only curative treatment for bone marrow failure (BMF) and hematologic complications of Fanconi anemia (FA). The evolution remains affected by the toxicity, the risk of graft failure, and clonal evolution. This study aimed to identify factors affecting outcomes in FA patients [...] |
Use of Plasma-Rich in Growth Factors (PRGF) in the Treatment of AcneAbstract Acne is a chronic inflammatory condition affecting the pilosebaceous units of the skin, characterized by the formation of papules, cysts, comedones, pustules, nodules, and scars. These lesions are typically located on the face and shoulders, although they can extend to the trunk, arms, and legs. In regenerative medicine, biomolecules are fundamental [...] |
Current and Future Applications of Machine Perfusion and Other Dynamic Preservation Strategies in Liver TransplantationAbstract Machine perfusion (MP) techniques, which simulate physiological conditions to allow for the assessment and preservation of organ viability, are currently applied in various solid organ transplantation fields. Owing to the growing demand for liver transplants and the scarcity of available donor livers, MP offers a practical solution for recovering high [...] |
Platelets as Regenerative Cells, Hundreds of Opportunities in SightAbstract Platelets were the last to be discovered of the three formed blood elements. Several scientists have been interested in them, recognizing them as cells other than leukocytes and erythrocytes. Its job in hemostasis and thrombosis is currently known. Platelets contain growth factors and secrete cytokines, which have roles in inflammation and tissue regene [...] |
Machine Perfusion of Donor Hearts – The Recovery and Transplantation of Previously Unrecoverable Heartsby
Sanjay Dutta
,
Jeanette E. Villanueva
,
Yashutosh Joshi
,
Ling Gao
,
Paul Jansz
and
Peter S. Macdonald
Abstract Heart transplantation remains the gold standard treatment for end-stage heart failure. With an increasing population and improving medical therapy there is an increasing number of patients who would benefit from heart transplantation but are unable to receive one due to a shortage of suitable donor organs. This ongoing need, and significant limitations [...] |
BK Virus-Associated Nephropathy in Adult Patients Post Kidney Transplantation: What Progress in 30 Years of History?Abstract Completely unknown before the 90s and exceptional up to the 2000s, BK virus nephropathy (BKvN), usually known as polyomavirus-associated nephropathy, has emerged as a significant and severe viral complication in kidney transplantation (KT). More than twenty years after Gardner's discovery of BKv in 1971, Purighalla described, in 1995, the first case [...] |
Impact of Intravenous Immunoglobulin Replacement Therapy on Hypogammaglobulinemia and Infection in Lung Transplant RecipientsAbstract Secondary hypogammaglobulinemia (HGG) from immunosuppression therapy in lung transplant recipients has been associated with increased mortality, morbidity and higher risk of infection. Intravenous immunoglobulin (IVIG) for the treatment of HGG post-lung transplant is not well studied with conflicting evidence regarding efficacy. This single-center, [...] |
Detection of Activated Pepsin in Bronchoalveolar Lavage and Acute Cellular Rejection in Lung Transplant RecipientsAbstract Activated pepsin (pepA) in bronchoalveolar lavage (BAL) fluid may be a biomarker of gastric aspiration. We sought to i) evaluate the association of pepA in BAL fluid with acute cellular rejection (ACR) in a cohort of lung transplant recipients (LTRs), ii) assess the association between pepA and isolation of typical gastrointestinal microorganisms from [...] |
Management of Calcareous Corneal Degeneration from Medication Washout to Corneal Transplantation. Case Series and Review of the LiteratureAbstract Calcareous corneal degeneration is a rare disease characterized by calcium phosphate deposition into the deep corneal layers. Corneal calcification has a multifactorial origin and is associated with various systemic and ocular conditions. Several treatment options showed promising results in the management of this disorder. Herein, two cases of calcareo [...] |
Circulating lncRNAs HOTTIP and HOTAIR as Potential Biomarkers in Crigler-Najjar Syndrome: A Preliminary Report from Shiraz Liver Transplant Research Centerby
Nasrin Motazedian
,
Masoud Mokhtari
,
Negar Azarpira
,
Kimia Falamarzi
,
Mohsen Mohammadi
,
Seyed Mohsen Dehghani
,
Sarina Pourjafar
,
Maryam Ataollahi
,
Elaheh Esfandiari
,
Mahdokht Hossein-Aghdaie
,
Seyed Ali Malekhosseini
,
Tayebeh Kazemi
and
Mahintaj Dara
Abstract Crigler-Najjar syndrome (CNS) is a rare autosomal recessive disorder characterized by impaired bilirubin metabolism, leading to neurotoxic unconjugated bilirubin accumulation. Liver transplantation remains the only effective treatment, highlighting the need for novel diagnostic and therapeutic approaches. Long non-coding RNAs (lncRNAs) have emerged [...] |
Is Donation after Circulatory Determination of Death in Japan Uncontrolled or Controlled?Abstract Using donation after circulatory determination of death (DCD) donors has been shown to be a potential means of increasing the number of donors for organ transplantation. The purpose of this study was to examine the published practice of DCD in Japan to properly define their practice as controlled or uncontrolled. Through the Web of Science database [...] |
Advances in Managing Infections in Lung Transplantation: A Reviewby
Shourjo Chakravorty
and
Ashka Patel
Abstract Transplanted lung allografts are particularly susceptible to infection among SOT due to the constant exposure to the environment, aggressive immunosuppressive strategies, and impaired clearance mechanisms after denervation of the transplanted lung. Though prophylactic antimicrobial, antifungal, and antiviral regimens are used as preventive strategies [...] |
Frequency of Unplanned Readmissions Following Lung Transplantation During the SAR-COV-2 Pandemic When Hospital Resources Were Strainedby
Justin Cole
,
Eugene Golts
,
Michael Bernales
,
Dina Shirazi
,
Deepa Kurup
,
Sarah Golts
,
Gordon Yung
,
Aarya Kafi
,
Christine M. Lin
,
Travis Pollema
and
Kamyar Afshar
Abstract Despite the concerted efforts by lung transplant recipients (LTR) and their medical teams, hospital readmissions are common in the first year following transplantation. Reasons for unplanned readmissions include allograft rejection, infections, and respiratory failure before the SARS-COV-2 pandemic. Clinical predictors of readmissions have changed over [...] |
Low Mortality Associated with COVID-19 Infection in Lung Transplant Recipients at a Single Centerby
Rahul F. Gomez
,
Aarya Kafi
,
Gordon Yung
,
Saima Aslam
,
Christine M. Lin
,
Travis Pollema
,
Eugene Golts
and
Kamyar Afshar
Abstract Lung Transplant Recipients (LTR) are particularly vulnerable to severe infection, hospitalization, and death due to community acquired respiratory viruses. As a result, the global SARS-Cov-2 pandemic poses a higher risk to this population. We aim to study the lung function, severity of infection and mortality among LTR at a single center. A retrospectiv [...] |
Contribution of a Single Islet Transplant Program to Basic Researchers in North America, Europe, and Asia through Distributing Human Isletsby
Tatsuya Kin
,
Doug O'Gorman
,
Wendy Zhai
,
Jennifer Moriarty
,
Kyle Park
,
Advaita Ganguly
,
Shawn Rosichuk
and
AM James Shapiro
Abstract There has been a steady expansion in islet isolation and transplantation activity worldwide. In addition to preparing human islets for transplantation, we have been providing human islets to basic researchers. The aim of this study was to review the activity of distribution of human islets to basic researchers in North America, Europe, and Asia, and [...] |
Thrombotic Microangiopathy in Solid Organ Transplantationby
Sravanthi Nandavaram
,
Hannah Twist
,
Rickey Evans
,
Sravanthi Paluri
,
Ana Castellanos
and
Andres Pelaez
Abstract Thrombotic Microangiopathy (TMA) is a syndrome characterized by microangiopathic hemolytic anemia (MAHA) and thrombocytopenia. The presence of schistocytes on peripheral smear, a negative Coombs test, elevated lactate dehydrogenase, increased reticulocyte count and low haptoglobin are often the clues for MAHA. The microvascular process often targets [...] |
Management of Steatosis in Living Donors: Where Do We Stand?Abstract With the progressive rise in rates of liver transplantation, stagnant donor pool, and social factors, living donor liver transplantation (LDLT) forms the majority of liver transplantations performed in Asian countries. As the global prevalence of metabolic-associated fatty liver disease (MAFLD) is increasing, around 17-25% of all the prospective donors [...] |
Airway Complications after Lung TransplantationAbstract Lung transplantation in patients with end stage lung disease can improve survival and quality of life. Airway complication incidence varies between 2-33%, but the true incidence is difficult to determine due to a lack of validated classification systems. There are many risk factors for post lung transplant airway complications, the most common being [...] |
Calculated Human Leucocyte Antigens Evolutionary Divergence (cHED)by
Bruno A Lima
Abstract Human Leucocyte Antigens (HLA) constitute a highly polymorphic set of genes pivotal to the immune response. The HLA heterozygous advantage hypothesis assumes that heterozygous individuals at the HLA level have a wider range of peptides for T cell recognition than homozygous individuals. Consequently, they possess an enhanced capacity to trigger a target [...] |
Chronic Lung Allograft Dysfunction, a Review in 2023Abstract Chronic allograft dysfunction (CLAD) is one of the leading causes of death after lung transplantation [1]. CLAD is a progressive and irreversible decline in lung function after transplant, manifested as an obstructive, restrictive, or mixed ventilatory impairment without any identifiable etiology as infection or acute rejection. Multiple risk factors [...] |
Evaluation of Total Parenteral Nutrition in the Autologous Transplantation Setting in Patients with AML: A Retrospective Exploratory Analysisby
Sarah Willi
,
Ulrike Bacher
,
Marie Noelle Kronig
,
Michael Daskalakis
,
Lia Bally
and
Thomas Pabst
Abstract Malnutrition remains a clinical challenge in AML patients undergoing autologous hematopoietic stem cell transplantation (ASCT), leading to physical deconditioning and prolonged hospitalization. Prospective data are mainly lacking to identify those patients who may particularly benefit from parenteral nutrition in this setting. This observational, non [...] |
Acknowledgement to Reviewers of OBM Transplantation in 2023Abstract The editors of OBM Transplantation would like to express their sincere gratitude to the following reviewers for assessing manuscripts in 2023. We greatly appreciate the contribution of expert reviewers, which is crucial to the journal’s editorial process. We aim to recognize reviewer contributions through several mechanisms, of which the annual public [...] |
Immune-Suppression Modulation in Solid Organ Transplant Recipients Admitted for COVID-19by
Francesco Peracchi
,
Giovanna Travi
,
Marco Merli
,
Roberto Rossotti
,
Fulvio Crippa
and
Massimo Puoti
Abstract SARS-CoV-2 infection has significantly impacted solid organ transplant (SOT) recipients, who are at high risk of disease and worse outcomes. Moreover, therapeutic management in this population is not precise yet. Our study aimed to evaluate the overall survival of SOT recipients and predictive factors for mortality. We also aimed to assess the impact [...] |
Lung Donor Selection and Management: An Updated Reviewby
Shefali Mody
,
Soham Nadkarni
,
Shreyash Vats
,
Akshay Kumar
,
Sravanthi Nandavaram
and
Suresh Keshavamurthy
Abstract The shortage of donor lungs for transplantation is a major challenge, resulting in longer waitlist times for patients with a higher risk of waitlist mortality. It is crucial to continue promoting awareness about organ donation through legislation, public campaigns, and health care provider education. Only a small number of cadaveric donors meet the [...] |
OBM Transplantation Welcomes New Editorial Board Member
We welcome Prof. Massimo Pinzani from University College London (UK) and ISMETT UPMC (Italy) to join the Editorial Board of OBM Transplantation. Dr. Pinzani is a UCL Emeritus Professor of Medicine, clinical hepatologist, formerly Director of the UCL Institute for Liver and Digestive Health and the Sheila Sherlock Chair of Hepatology at UCL and currently Scientific Director of ISMETT UPMC in Palermo, Italy. He has extensive experience in cell and molecular biology, liver diseases, liver regenerative medicine, cirrhosis, fibrosis, liver transplantation, liver cancer, hepatocellular carcinoma, etc. We are grateful to Prof. Pinzani for his participation and support.
OBM Transplantation Welcomes New Editorial Board Member
We welcome Prof. Hidenori Otsuka from Tokyo University of Science, Japan, to join the Editorial Board of OBM Transplantation. Dr. Otsuka is a Professor of the Department of Applied Chemistry at Tokyo University of Science. He has extensive experience in colloid and interface, polymer chemistry, biomaterial, medical polymer, tissue engineering, drug delivery system, nanozyme. We are grateful to Prof. Otsuka for his participation and support.
OBM Transplantation Welcomes New Editorial Board Member
We welcome Prof. Gerhard C. Hildebrandt from University of Missouri, USA, to join the Editorial Board of OBM Transplantation. Dr. Hildebrandt is a Professor of Medicine, Nellie B. Smith Endowed Chair of Oncology, Division Chief of Hematology and Medical Oncology at the School of Medicine, and Director of Ellis Fischel Cancer Center. He has extensive experience in bone marrow stem cell transplantation, blood stem cell transplantation, chimeric antigen receptor T (CAR-T) cell therapy, graft-versus-host disease, impact of the metabolome and microbiome on clinical outcomes in blood cancers and after bone marrow transplantation. We are grateful to Prof. Hildebrandt for his participation and support.
OBM Transplantation Welcomes New Editorial Board Member
We welcome Prof. Jacek Z. Kubiak from University Rennes, France, to join the Editorial Board of OBM Transplantation. Dr. Kubiak is a Professor of Cell and Molecular Biology. He has extensive experience in cell cycle, early development, macrophages, liver transplantation, cytoskeleton, protein kinases and phosphatases, stem cells. We are grateful to Prof. Kubiak for his participation and support.
OBM Transplantation Welcomes New Editorial Board Member
We welcome Prof. Leopoldo Spadea from La Sapienza University of Rome, Italy, to join the Editorial Board of OBM Transplantation. Prof. Spadea is a Clinical Professor of Ophthalmology and the head of Eye Clinic of Policlinico Umberto I at La Sapienza University of Rome. He has extensive experience in corneal topography, excimer laser refractive procedures (PRK and LASIK), corneal collagen cross-linking and corneal transplantations. We are grateful to Prof. Spadea for his participation and support.
OBM Transplantation Welcomes New Editorial Board Member
We welcome Prof. Jerome Roncalli from University Hospital of Toulouse, France, to join the Editorial Board of OBM Transplantation. Dr. Roncalli is a Professor of Cardiology at the University Hospital of Toulouse. He has extensive experience in interventional cardiology, heart failure, tissue repair and regeneration, progenitor and adult stem cells. We are grateful to Prof. Roncalli for his participation and support.
OBM Transplantation Welcomes New Editorial Board Member
We welcome Dr. Mazaher Gholipourmalekabadi from Iran University of Medical Sciences, Iran, to join the Editorial Board of OBM Transplantation. Dr. Gholipourmalekabadi is an Associate Professor of the Department of Medical Biotechnology at Iran University of Medical Sciences. He has extensive experience in biomaterials, tissue engineering, stem cells, medical biotechnology. We are grateful to Dr. Gholipourmalekabadi for his participation and support.
OBM Transplantation Welcomes New Editorial Board Member
We welcome Dr. Anthony Papp from University of British Columbia, Canada, to join the Editorial Board of OBM Transplantation. Dr. Anthony Papp is the Medical Director of the BC Professional Firefighters' Burn Unit and a Clinical Professor in the Department of Surgery at the University of British Columbia. He is a plastic surgeon who has extensive experience in burn and wound care, scar management, plastic surgery and reconstructive surgery. We are grateful to Dr. Papp for his participation and support.
OBM Transplantation Welcomes New Editorial Board Member
We welcome Dr. Eric M. Bluman from Brigham and Women's Hospital, USA, to join the Editorial Board of OBM Transplantation. Dr. Bluman is an Associate Professor in the Department of Orthopedic Surgery at Harvard Medical School. He has extensive experience in orthopaedic surgery, complex reconstruction of foot and ankle deformity, cartilage transplantation, allograft ligament reconstruction, and bone grafting. We are grateful to Dr. Bluman for his participation and support.
OBM Transplantation Welcomes New Editorial Board Member
We welcome Dr. Miriana d'Alessandro from University of Siena, Italy, to join the Editorial Board of OBM Transplantation. Dr. d'Alessandro is a renowned scholar who has extensive experience in pulmonary fibrosis, interstitial lung disease, bronchoalveolar lavage, immunology, respiratory diseases, flow cytometry, extracellular vesicles. We are grateful to Dr. d'Alessandro for her participation and support.
OBM Transplantation Welcomes New Editorial Board Member
We welcome Dr. Sotiria Palioura from Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, USA, to join the Editorial Board of OBM Transplantation. Dr. Palioura is a renowned scholar who has extensive experience in cornea transplantation, cataract surgery, refractive surgery, management of ocular surface tumors and inflammatory diseases. We are grateful to Dr. Palioura for her participation and support.
OBM Transplantation Welcomes New Editorial Board Member
We welcome Prof. Gaetano Isola from University of Catania, Italy, to join the Editorial Board of OBM Transplantation. Dr. Isola is an Associate Professor of Periodontology at the University of Catania. He has extensive experience in periodontal disease, oral medicine, oral biology. We are grateful to Prof. Isola for his participation and support.
OBM Transplantation Welcomes New Editorial Board Member
We welcome Dr. Jeffrey J. Pu from the Harvard Medical School, USA, to join the Editorial Board of OBM Transplantation. Dr. Pu is an Associate Professor of Medicine. He has extensive experience in hematopoietic mechanism of hematological malignant disease progression, stem cell biology, biomarker translational research, cellular therapy, early phase clinical trials, and HCTT outcome-research. We are grateful to Dr. Pu for his participation and support.
OBM Transplantation Welcomes New Editorial Board Member
We welcome Dr. Clotilde Castaldo from University of Naples Federico II, Italy, to join the Editorial Board of OBM Transplantation. Dr. Castaldo is a Full Professor of the Department of Public Health at University of Naples Federico II. She has extensive experience in adult stem cells, iPSCs, 3D cell culture, decellularization, cardiac tissue engineering, and regenerative medicine. We are grateful to Dr. Castaldo for her participation and support.
OBM Transplantation Welcomes New Editorial Board Member
We welcome Dr. Luca Testarelli from Sapienza University of Rome, Italy, to join the Editorial Board of OBM Transplantation. Dr. Testarelli is an Associate Professor of the Department of Oral and Maxillofacial Sciences at the Sapienza University of Rome. He has extensive experience in endodontics, oral surgery, 3D in dentistry, implantology, dental materials. We are grateful to Dr. Testarelli for his participation and support.
OBM Transplantation Welcomes New Editorial Board Member
We welcome Dr. Christopher Bibbo from Sinai Hospital of Baltimore, USA, to join the Editorial Board of OBM Transplantation. Dr. Bibbo is the Head of Foot and Ankle Surgery and the Assistant Director of the Foot and Ankle Deformity Correction and Orthoplastics Fellowship at the International Center for Limb Lengthening. He has extensive experience in foot and ankle treatment, foot and ankle sports medicine, plastic reconstructive & microsurgery, peripheral nerve reconstruction, orthopedic trauma and musculoskeletal infections. We are grateful to Dr. Bibbo for his participation and support.
OBM Transplantation Welcomes New Editorial Board Member
We welcome Prof. James F. Thornton from University of Texas Southwestern Medical Center, USA, to join the Editorial Board of OBM Transplantation. Prof. Thornton is a Professor in the Department of Plastic Surgery at the University of Texas Southwestern Medical Center at Dallas, and is the holder of the Ellen Hecht Chair in tissue transplantation. He has extensive experience in skin, plastic surgery, Mohs reconstruction, reconstructive breast surgery, head and neck reconstruction, upper and lower extremity reconstruction, abdominal wall reconstruction. We are grateful to Prof. Thornton for his participation and support.
OBM Transplantation Welcomes New Editorial Board Member
We welcome Dr. Antonino Maniaci from Kore University of Enna, Italy, to join the Editorial Board of OBM Transplantation. Dr. Maniaci is a renowned scholar who has extensive experience in rhinology, OSAS, laryngology, otolaryngology, salivary gland, head and neck, ENT surgery. We are grateful to Dr. Maniaci for his participation and support.
OBM Transplantation Welcomes New Editorial Board Member
We welcome Prof. Anastasiia V. Bondarenko from International European University, Ukraine, to join the Editorial Board of OBM Transplantation. Prof. Bondarenko is the Head of the Department of Pediatrics, Immunology, Infectious and Rare Diseases at International European University. She has extensive experience in primary immunodeficiencies, infectious diseases, immunology of infectious diseases, vaccines, immunoprophylaxis. We are grateful to Prof. Bondarenko for her participation and support.
It is our pleasure to announce that LIDSEN has joined the ORCID community. ORCID (Open Researcher and Contributor ID), a global, not-for-profit organization, provides a free, unique, and persistent digital identifier (an ORCID iD), which can automatically link researchers to their own contributions, so as to disambiguate researchers from one another. Authors who publish with OBM Transplantation are greatly encouraged to register for a unique iD to ensure proper attribution.
OBM Transplantation Welcomes New Editorial Board Member
We welcome Prof. Maurizio Salvadori from Careggi University Hospital, Italy, to join the Editorial Board of OBM Transplantation. Prof. Salvadori is a Professor, Professor, Department of Renal Transplantation, Careggi University Hospital, viale Pieraccini 18, 50139 Florence, Italy. Prof. Salvadori has extensive experience in kidney transplantation, transplantation, clinical nephrology, chronic renal failure, immunology, infectious diseases, and antibody-mediated rejection. We are grateful to Prof. Salvadori for his participation and support.
OBM Transplantation Welcomes New Editorial Board Member
We welcome Dr. Tatsuya Kin from University of Alberta, Canada, to join the Editorial Board of OBM Transplantation. Dr. Kin is the Director, Clinical Islet Laboratory, Department of Surgery, University of Alberta, 112 Street & 87 Avenue, Edmonton, AB T6G 2E1, Canada. Dr. Kin has extensive experience in islet isolation, islet transplantation, organ preservation, organ donation, transplantation, and diabetes. We are grateful to Dr. Kin for his participation and support.
OBM Transplantation Welcomes New Editorial Board Member
We welcome Prof. Luca Brazzi from University of Turin, Italy, to join the Editorial Board of OBM Transplantation. Prof. Brazzi is a Professor, Chief, Director, Department of Surgical Science, University of Turin, University Hospital Città della Salute e della Scienza, Corso Dogliotti 14, 10126 Turin, Italy. Prof. Brazzi has extensive experience in anaesthesiology, transplant anaesthesiology, anaesthetics, and preservation of donor organs. We are grateful to Prof. Brazzi for his participation and support.
OBM Transplantation Welcomes New Editorial Board Member
We welcome Dr. Nidhi Sharma from Ohio State University, USA, to join the Editorial Board of OBM Transplantation. Dr. Sharma is from Division of Hematology, Comprehensive Cancer Center, Ohio State University Wexner Medical Center, Columbus, OH, USA. Dr. Sharma’s research interest is in the field of stem cell transplantation (autologous and allogenic), and graft vs host disease (GVHD). We are grateful to Dr. Sharma for the participation and support.
OBM Transplantation Welcomes New Editorial Board Member
We welcome Prof. Marina Moguilevitch from Montefiore Medical Center, Albert Einstein College of Medicine, USA, to join the Editorial Board of OBM Transplantation. Prof. Moguilevitch is an Associate Professor of Clinical Anesthesiology, Director of Transplant Anesthesia Service, Divsion of Transplant Anesthesiolgy, Department of Anesthesiology, Montefiore Medical Center, Albert Einstein College of Medicine, New York, NY, USA. She has extensive experience in anesthesiology, transplant anesthesiology, and liver transplantation. We are grateful to Prof. Moguilevitch for her participation and support.
OBM Transplantation Welcomes New Editorial Board Member
We welcome Prof. Malcolm Voyce from Macquarie Law School, Macquarie University, Australia, to join the Editorial Board of OBM Transplantation. Prof. Voyce is a Professor of Law, Macquarie Law School, Macquarie University, NSW 2109 Australia. He has extensive experience in property law and succession concerning the privatisation of public property, geographical indications, intellectual property rights, social welfare, family farm inheritance and organ transplants, law and religion, and Buddhism and Islam. We are grateful to Prof. Voyce for his participation and support.
OBM Transplantation Welcomes New Editorial Board Member
We welcome Dr. Maricar Malinis from Yale School of Medicine, USA, to join the Editorial Board of OBM Transplantation. Dr. Malinis is an Associate Professor of Medicine and Surgery (Transplant), Medical Director, Transplant Infectious Diseases, Section of Infectious Diseases, Yale School of Medicine, New Haven, CT, USA. She has extensive experience in aging, CMV, fungal infections, immunocompromised host and transplant infectious diseases. We are grateful to Dr. Malinis for her participation and support.
OBM Transplantation Welcomes New Editorial Board Member
We welcome Professor Paolo Muiesan from Queen Elizabeth & Birmingham Children's Hospitals, USA, to join the Editorial Board of OBM Transplantation. Professor Muiesan is the Professor of HPB Surgery & Liver Transplantation, Liver Unit, Queen Elizabeth & Birmingham Children's Hospitals, Mindelsonway, Birmingham B15 2TH, United Kingdom. He has extensive experience in adult and paediatric liver transplantation, hepatobiliary surgery, liver tumors, general surgery, vascular surgery, laparoscopic liver surgery, liver resections for cholangiocarcinoma, parenchymal sparing central resections, ALPPS and ex-vivo resections. We are grateful to Prof. Muiesan for his participation and support.
OBM Transplantation Welcomes New Editorial Board Member
We welcome Professor Mohammed Moghadasian from University of Manitoba, Canada, to join the Editorial Board of OBM Transplantation. Professor Moghadasian is the Professor of Nutrition, Department of Food and Human Nutritional Sciences, University of Manitoba, Winnipeg, Manitoba, Canada. He has extensive experience in diet, lipoprotein metabolism, coronary artery disease, diet-drug interaction, and diets and transplantation. We are grateful to Prof. Moghadasian for his participation and support.
OBM Transplantation Welcomes New Editorial Board Member
We welcome Dr. Esma S. Yolcu to join the Editorial Board of OBM Transplantation. Dr. Yolcu is an Associate Professor at Department of Microbiology and Immunology, Institute for Cellular Therapeutics, University of Louisville School of Medicine, Louisville, USA. Her main research interests are immunotherapy, ProtEx™ technology, gene therapy, immunomodulation, tolerance, host-versus-graft (HVG) and graft-versus-host (GVH). We are grateful to Dr. Yolcu for her participation and support.
OBM Transplantation welcomes the following types of articles: original research, review, communication, opinion, case report, comment, conference report, technical note, book review, etc. There is no restriction on the length of the papers, color figures, supplementary file types. More details please see Instructions for Authors.
2023 | ||
CiteScore | SJR | SNIP |
0.6 | 0.179 | 0.17 |
Original Research
by Tatsuya Kin et al.
OBM Transplantation 2024
Published: 03 June 2024
Original Research
by Nasrin Motazedian et al.
OBM Transplantation 2024
Published: 04 June 2024
Original Research
by Andrés R. Latorre-Rodríguez et al.
OBM Transplantation 2024
Published: 21 June 2024
Review
by Yassamine Bentata
OBM Transplantation 2024
Published: 25 July 2024
Review
by Sanjay Dutta et al.
OBM Transplantation 2024
Published: 05 August 2024
TOP